Company Profile
Updated: 18-DEC-09Molecular Biologics Inc.
Private Company, Headquarters Location
2011 N 1800 W, Lindon, UT 94042, United States
(800)321-3740, (801)796-8742, (801)796-8747 fax,
Primary SIC: Frozen Specialties, Not Elsewhere Classified, Primary NAICS: Frozen Specialty Food Manufacturing
Description: Frozen Specialties, Not Elsewhere Classified
View this company profile - Now for a Limited Time, try Goliath Company Profiles
Free for 3 Days!
Fate Therapeutics' iPSC Technology Awarded Top Industry Honors for Small Molecule and Protein Reprogramming Breakthroughs.
PR Newswire; 12/21/2009; 1196 words; ...PRNewswire/ -- Fate Therapeutics, Inc. announced today that the Company...development of small molecules and biologics to modulate cell fate for therapeutic...understand diseases and to elucidate molecular targets for drug discovery...About Fate Therapeutics, Inc. Fate Therapeutics is ...
YM BioSciences Inc. and Therapure Biopharma Inc. Announce Contract.
PR Newswire; 12/17/2009; 1372 words; ...Therapure Biopharma Inc. today announced...CIMYM BioSciences Inc., by the Centre of Molecular Immunology (CIM...from the Center Molecular Immunology with...the production of biologics and provides a...Therapure Biopharma Inc. is an integrated...
Studies from G. Castaman et al further understanding of hemophilia a.
Blood Weekly; 12/3/2009; 993 words; ...relationship of the biologic response to desmopressin...prospectively assessed the molecular and phenotypic determinants of the biologic response to desmopressin...and Haemostasis (Molecular and phenotypic determinants...Blackwell Publishing, Inc., Commerce Place...
Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities.
PR Newswire; 12/2/2009; 2340 words; ...Trends & Opportunities" by BizAcumen, Inc. Our reports are designed to be most...Corporation 28 CMC Announces Acquisition of ICOS Biologics Facility from Eli Lilly 28 SurModics Acquires...Acquisition of Prous Science 35 MDS Acquires Molecular Devices 36 Evotec to Take over Renovis...
Pfizer and DNDi Advancing International Research Efforts In the Fight Against Neglected Tropical Diseases.
Vaccine Weekly; 12/2/2009; 1480 words; Pfizer Inc and Drugs for Neglected...treatments (see also Pfizer Inc). "Despite considerable...Institute for Cell and Molecular Therapies, Griffith University...patient needs. Pfizer Inc: Working together for...includes human and animal biologic and small molecule medicines...
Recent News Articles
- Molecular biological tools to assess bioremediation.(CORPORATE PROFILE / MICROBIAL INSIGHTS INC.)
Pollution Engineering - July 01, 2007 - Lonza, Chromos sign gene pact. (Pharmaceuticals & Fine Chemicals).(Lonza Biologics; Chromos Molecular Systems Inc)
Chemical Week - June 19, 2002
Why Purchase This Company Profile?
- Sales prospecting
- Competitive analysis
- Vendor & supplier evaluation
- Customer evaluation and analysis
- Strategic planning